Merck research chief Roger Perlmutter touts Seattle biotech strength after $300M Immune Design deal by James Thorne on April 24, 2019April 24, 2019 at 11:03 am Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter, says the city’s life science community has plenty more to… Read More